CLL Academy – IACH Journal Club – Zanubrutinib and Venetoclax for Patients With Treatment-Na¨ ıve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With and Without Del(17p)/TP53 Mutation: SEQUOIA Arm D Results – Tuesday, July 8, 2025
Open to access this content







